Source link : https://www.newshealth.biz/health-news/do-frail-nstemi-patients-benefit-from-an-invasive-approach/
TOPLINE: In patients with non-ST-elevation myocardial infarction (NSTEMI) and frailty, an initial invasive strategy caused early harm followed by late benefit, resulting in a neutral effect on survival at 3 years, randomized trial results suggested. METHODOLOGY: The MOSCA-FRAIL trial, conducted at 13 hospitals in Spain, included 167 adults (mean age, 86 years) with frailty (Clinical […]
Author : News Health
Publish date : 2024-03-19 09:19:31
Copyright for syndicated content belongs to the linked Source.